- Home
- FIVN vs IMVT Comparison
FIVN vs IMVT Comparison
Compare FIVN & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVN
- IMVT
- Stock Information
- Founded
- FIVN 2001
- IMVT N/A
- Country
- FIVN United States
- IMVT United States
- Employees
- FIVN N/A
- IMVT N/A
- Industry
- FIVN EDP Services
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FIVN Technology
- IMVT Health Care
- Exchange
- FIVN Nasdaq
- IMVT Nasdaq
- Market Cap
- FIVN 2.3B
- IMVT 2.5B
- IPO Year
- FIVN 2014
- IMVT N/A
- Fundamental
- Price
- FIVN $26.51
- IMVT $14.85
- Analyst Decision
- FIVN Buy
- IMVT Buy
- Analyst Count
- FIVN 20
- IMVT 10
- Target Price
- FIVN $44.40
- IMVT $40.14
- AVG Volume (30 Days)
- FIVN 1.9M
- IMVT 1.2M
- Earning Date
- FIVN 05-01-2025
- IMVT 05-29-2025
- Dividend Yield
- FIVN N/A
- IMVT N/A
- EPS Growth
- FIVN N/A
- IMVT N/A
- EPS
- FIVN N/A
- IMVT N/A
- Revenue
- FIVN $1,074,633,000.00
- IMVT N/A
- Revenue This Year
- FIVN $11.81
- IMVT $108.88
- Revenue Next Year
- FIVN $9.70
- IMVT N/A
- P/E Ratio
- FIVN N/A
- IMVT N/A
- Revenue Growth
- FIVN 14.44
- IMVT N/A
- 52 Week Low
- FIVN $21.04
- IMVT $12.72
- 52 Week High
- FIVN $49.90
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- FIVN 49.59
- IMVT 50.48
- Support Level
- FIVN $25.45
- IMVT $13.79
- Resistance Level
- FIVN $27.54
- IMVT $15.22
- Average True Range (ATR)
- FIVN 0.91
- IMVT 0.69
- MACD
- FIVN -0.00
- IMVT 0.13
- Stochastic Oscillator
- FIVN 32.27
- IMVT 78.24
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).